Llera, Aubrey Fhebygaile E.

HRN: 20-15-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2026
CEFUROXIME 500MG (TAB)
02/22/2026
03/01/2026
PO
500mg
BID X 7 Days
S/P NSVD With Perineorrhaphy; Non-institutional Delivery
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: